Administrative Core
Administrative Core
批准号:
8328002
负责人:
JOEL Barry BASEMAN
金额:
$19.45万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2016-07-31
关键词:
AcuteAdultAdvisory CommitteesAllergic DiseaseAsthmaBiochemistryBudgetsChildChronicCommunicationCommunity Acquired Respiratory Distress Syndrome ToxinConsultationsDevelopmentDiagnosticEffectivenessEnsureEpidemiologyEquipmentEthicsExperimental DesignsFunctional disorderFundingFunding OpportunitiesHousingIACUCImmunologyInstitutional Review BoardsInstructionLeadLeadershipLinkLungManuscriptsMedical StudentsMedicineMicrobiologyModificationMonitorMycoplasma pneumoniaeNational Institute of Allergy and Infectious DiseaseOccupational activity of managing financesPathologyPediatricsPerformancePostdoctoral FellowPreventionProgress ReportsReagentRelative (related person)ResearchResearch InfrastructureResearch PersonnelResource AllocationResourcesRoleSamplingScheduleTestingTherapeuticTimeLineToxinTrainingWorkcost effectivenessdata managementgraduate studentmeetingsmembernovel diagnosticsnovel therapeuticsprogramsresearch studysymposium
中文摘要
圣安东尼奥哮喘和过敏性疾病合作研究中心的长期目标
(SA-AADCRC)行政核心(AC)是:提供项目的领导和全面协调
和组成SA-AADCRC的核心,并促进调查人员和其他人员之间的交互
NIAID资助的AADCRCs,使跨学科的专业知识和测试样本和试剂产生
共享项目和核心,以实现最大影响和成本效益。萨阿德儿童权利公约的主要重点
应用是鉴定和阐明肺炎支原体的作用及其独特的
社区获得性呼吸窘迫综合征毒素(CADS TX),真正的ADP核糖化和
空泡毒素,并将其与新发哮喘、哮喘加重和长期肺病联系在一起。
儿童和成人的功能障碍。SA-AADCRC的成员包括来自
生物化学、微生物学和免疫学、医学、病理学和儿科以及
AC将继续支持这个紧密联系和协作的小组,并确保所有义务和
实现了时间表,SA-AADCRC和NIAID之间的关系和沟通
其他由NIAID赞助的AADCRC是高效、有益和协作的。AC的具体目标是:协助
全面管理和协调SA-AADCRC在调查员和NIAID之间的活动
工作人员和其他AADCRC;定期与项目和核心领导层及受训人员会面(本科生和
医学生、博士后研究员和住院医生),以评估战略和进展、需求和资源
分配;建议修改试验设计和研究方向,咨询
调查员和NIAID;安排定期的内部研究会议和进行中的会议
以及内部和外部发言者研讨会;帮助财务管理和重新编制预算
各自的儿童权利中心项目和核心;审阅手稿和进度报告;执行日常工作
行政活动,以促进南非-非洲反兴奋剂机构以及整个
NIAID赞助的AADCRC成员;并促进翻译信息的传输(诊断、
治疗)给UTHSCSA、NIAID和潜在的工业合作伙伴。AC的其他职责将
促进最大限度地利用资源,以开发新的诊断和治疗方法
急慢性哮喘和过敏性疾病的治疗和预防。
英文摘要
The long term objectives of the San Antonio Asthma and Allergic Diseases Cooperative Research Center
(SA-AADCRC) Administrative Core (AC) are: to provide leadership and overall coordination of the projects
and cores that comprise the SA-AADCRC and to facilitate interactions between investigators and other
NIAID-funded AADCRCs, so that cross-disciplinary expertise and test samples and reagents generated by
projects and cores are shared for maximum impact and cost effectiveness. The major focus of the SAAADCRC
application is to identify and elucidate the roles of Mycoplasma pneumoniae and its unique
Community Acquired Respiratory Distress Syndrome ToXin (CARDS TX), a bona fide ADP ribosylating and
vacuolating toxin, and link them to new-onset asthma, exacerbations of asthma, and long-term pulmonary
dysfunction in children and adults. The membership of the SA-AADCRC includes investigators from the
Departments of Biochemistry, Microbiology and Immunology, Medicine, Pathology, and Pediatrics and the
AC will continue to support this closely knit and collaborative group and ensure that all obligations and
timelines are achieved and that relationships and communication between the SA-AADCRC and NIAID and
other NIAID-sponsored AADCRCs are efficient, helpful and collaborative. The AC specific aims are: assist
in the overall management and coordination of activities ofthe SA-AADCRC among investigators and NIAID
staff and other AADCRCs; meet regularly with project and core leadership and trainees (graduate and
medical students, postdoctoral fellows and residents) to assess strategies and progress, needs and resource
allocation; recommend modifications of experimental design and research direction in consultation with key
investigators and NIAID; schedule regular in-house research conferences and work-in-progress sessions
and internal and external speaker seminars; help in the financial management and re-budgeting of the
respective CRC projects and cores; review manuscripts and progress reports; perform the day-to-day
administrative activities in order to facilitate effectiveness of the SA-AADCCRC as well as of the entire
NIAID-sponsored AADCRC members; and promote the transfer of translational information (diagnostics,
therapeutics) to UTHSCSA, NIAID and potential industrial partners. Additional AC responsibilities will
promote maximal usage of resources in order to develop new and novel diagnostics and therapeutics for the
treatment and prevention of acute and chronic asthma and allergic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of host cell invasion in Mycoplasma genitalium persistent infection
-
批准号:9197256
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2015
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Biochemical, molecular and immunological characterization of Mycoplasma pneumoni
-
批准号:8328001
-
项目类别:
-
资助金额:$42.24万
-
财政年份:2011
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Infrastructure and Opportunity Fund Management
-
批准号:8328003
-
项目类别:
-
资助金额:$83.49万
-
财政年份:2011
-
负责人:JOEL Barry BASEMAN
-
依托单位:
San Antonio STI TM CRC
-
批准号:7921828
-
项目类别:
-
资助金额:$54.72万
-
财政年份:2009
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma
-
批准号:7914874
-
项目类别:
-
资助金额:$40.79万
-
财政年份:2009
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Administrative Core
-
批准号:7686483
-
项目类别:
-
资助金额:$11.1万
-
财政年份:2008
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Biochemical, Molecular &Immunological Characterization of the Mycoplasma pneumon
-
批准号:7686482
-
项目类别:
-
资助金额:$26.31万
-
财政年份:2008
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Discretionary Projects
-
批准号:7686466
-
项目类别:
-
资助金额:$48.01万
-
财政年份:2008
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma
-
批准号:7274288
-
项目类别:
-
资助金额:$155.53万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i
-
批准号:8300811
-
项目类别:
-
资助金额:$203.36万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i
-
批准号:8705990
-
项目类别:
-
资助金额:$255.36万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma
-
批准号:7682873
-
项目类别:
-
资助金额:$149.49万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i
-
批准号:8164349
-
项目类别:
-
资助金额:$311.22万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i
-
批准号:8897848
-
项目类别:
-
资助金额:$205.36万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i
-
批准号:8513872
-
项目类别:
-
资助金额:$193.04万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Biochemical, Molecular and Immunological Characterization of the Mycoplasma pneum
-
批准号:7150764
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma
-
批准号:7134895
-
项目类别:
-
资助金额:$150.79万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Administrative Core
-
批准号:7150765
-
项目类别:
-
资助金额:$9.42万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma
-
批准号:7904191
-
项目类别:
-
资助金额:$150.08万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
MYCOPLASMA PNEUMONIAE: AIRWAY INTERPLAY
-
批准号:7349846
-
项目类别:
-
资助金额:$1.16万
-
财政年份:2006
-
负责人:JOEL Barry BASEMAN
-
依托单位:
海外基金